Symyx: Informatics Support for Biologics Research

Symyx Technologies is extending an invitation to life scientists in industry and academia to join an expanded Biologics Advisory Board. The purpose of the board is to encourage dialogue on core informatics strategies, technologies, and priorities supporting biologics workflows – including Web browser technology for biologics registration and integration of biologics registration capabilities into the enterprise Symyx Notebook ELN.

Over the next five years, the market for biologically-based drugs, or biologics, is expected to grow faster than the market for traditional small molecule-derived drugs. Biologics represent an increasing proportion of pharmaceutical company pipelines, often serving as the first line of defense against immune system diseases such as cancer, rheumatoid arthritis, and multiple sclerosis.